Otsuka Holdings Co., Ltd.: all 780 studies

Page 4 of 8. Open to participants first (58), then studies with results posted, then the rest; newest registration first within each.

• Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT01336972Phase 2Results posted
• Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple SclerosisCompletedNCT01324232Phase 2Results posted
• A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired SubjectsCompletedNCT01299454Phase 1Results posted
• Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired SubjectsCompletedNCT01289080Phase 1Results posted
• Diffuse Gastric and Esophagogastric Junction Cancer S-1 TrialTerminatedNCT01285557Phase 3Results posted
• A Study to Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan]CompletedNCT01280721Phase 3Results posted
• SGI-110 in Participants With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)CompletedNCT01261312Phase 1/2Results posted
• Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional HyponatremiaTerminatedNCT01227512Phase 3Results posted
• Tolvaptan Extension Study in Participants With ADPKDCompletedNCT01214421Phase 3Results posted
• Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKDCompletedNCT01210560Phase 2Results posted
• Efficacy & Safety Study of Oral Aripiprazole in Adolescents With SchizophreniaCompletedNCT01149655Phase 3Results posted
• Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive TuberculosisTerminatedNCT01131351Phase 2Results posted
• An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With SchizophreniaCompletedNCT01129882Phase 3Results posted
• To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01123707Phase 3Results posted
• Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.TerminatedNCT01122927Phase 3Results posted
• A Study to Investigate Pharmacodynamics and Pharmacokinetics of OPC-41061 in Patients With Hepatic EdemaCompletedNCT01114828Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111565Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111552Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111539Phase 3Results posted
• Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)CompletedNCT01084551Phase 3Results posted
• Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity DisorderCompletedNCT01074294Phase 2Results posted
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive DisorderCompletedNCT01052077Phase 2Results posted
• A Trial to Investigate the Efficacy of OPC-41061 Administered at a Dose of 7.5 mg in Patients With Hepatic EdemaCompletedNCT01050530Phase 3Results posted
• A Trial of OPC-41061 in Patients With Hepatic Edema - Investigation of the Safety of Treatment at 7.5 mg Beyond 7 Days and of the Effect of Dose Escalation to 15 mgCompletedNCT01048788Phase 3Results posted
• A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]CompletedNCT01022424Phase 3Results posted
• IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma PatientsCompletedNCT01009840Phase 2Results posted
• Oral Aripiprazole Open-Label Rollover StudyCompletedNCT01001702Phase 3Results posted
• A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid ArthritisCompletedNCT00993317Phase 3Results posted
• A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's DiseaseCompletedNCT00989573Phase 2/3Results posted
• PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma PatientsCompletedNCT00948090Phase 2Results posted
• To Investigate the Efficacy and Safety of OPC-6535 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00917150Phase 2Results posted
• Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute SchizophreniaCompletedNCT00905307Phase 2Results posted
• Confirmatory Study of OPC-12759 Ophthalmic SuspensionCompletedNCT00885079Phase 3Results posted
• Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive DisorderCompletedNCT00882362Phase 3Results posted
• Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive DisorderCompletedNCT00876343Phase 3Results posted
• Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With EmphysemaTerminatedNCT00874497Phase 2Results posted
• Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic SyndromeTerminatedNCT00857818Phase 3Results posted
• A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]CompletedNCT00841568Phase 2Results posted
• Phase II Study of TAS-109 to Treat Advanced Colorectal CancerTerminatedNCT00824161Phase 2Results posted
• Long Term Administration Study of OPC-12759 Ophthalmic SuspensionCompletedNCT00818324Phase 3Results posted
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderCompletedNCT00797966Phase 2Results posted
• Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)CompletedNCT00791999Phase 2/3Results posted
• Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)CompletedNCT00791921Phase 3Results posted
• Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical CancerCompletedNCT00770874Phase 3Results posted
• Phase II Study of TAS-106 to Treat Head and Neck CancerTerminatedNCT00737360Phase 2Results posted
• Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaCompletedNCT00731549Phase 3Results posted
• Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaCompletedNCT00706654Phase 3Results posted
• Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's DisorderCompletedNCT00706589Phase 3Results posted
• Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaCompletedNCT00705783Phase 3Results posted
• Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line TherapyTerminatedNCT00687596Phase 2Results posted
• A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)CompletedNCT00685360Phase 2Results posted
• Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular CarcinomaTerminatedNCT00667628Phase 2Results posted
• A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) PatientsCompletedNCT00666965Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I DisorderCompletedNCT00665366Phase 3Results posted
• Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic CancerCompletedNCT00651742Phase 2Results posted
• A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed EpisodeCompletedNCT00606320Phase 3Results posted
• A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed EpisodeCompletedNCT00606281Phase 3Results posted
• A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed EpisodeCompletedNCT00606229Phase 3Results posted
• A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed EpisodeCompletedNCT00606177Phase 3Results posted
• Safety and Efficacy of AVP-923 in PBA Patients With ALS or MSCompletedNCT00573443Phase 3Results posted
• Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic PatientsCompletedNCT00550459Phase 3Results posted
• A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)CompletedNCT00544869Phase 3Results posted
• A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease PatientsCompletedNCT00537485Phase 2/3Results posted
• A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)CompletedNCT00525265Phase 3Results posted
• Dose-ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to OsteoporosisCompletedNCT00504426Phase 2Results posted
• A Dose-defining Study of OPC-41061 in Treatment of Hepatic EdemaCompletedNCT00479336Phase 2Results posted
• Late Phase 2 Study of OPC-12759 Ophthalmic SuspensionCompletedNCT00475319Phase 2Results posted
• An Exploratory Study of Rebamipide in Patients With Active Ulcerative ColitisCompletedNCT00463151Phase 2Results posted
• A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)CompletedNCT00462670Phase 3Results posted
• Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT00428948Phase 3Results posted
• Tolvaptan Open-label Pilot Efficacy, Tolerability, and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT00413777Phase 2Results posted
• A Safety and Efficacy Study in Patients With Gastric CancerCompletedNCT00400179Phase 3Results posted
• Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-CompletedNCT00392197Phase 4Results posted
• Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)CompletedNCT00365859Phase 3Results posted
• Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)CompletedNCT00337571Phase 3Results posted
• Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).CompletedNCT00332241Phase 3Results posted
• A Dose-finding Study of OPC-6535 in Patients With Active Crohn's DiseaseTerminatedNCT00317369Phase 2Results posted
• A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative ColitisTerminatedNCT00317356Phase 2Results posted
• A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed EpisodeCompletedNCT00277212Phase 4Results posted
• A Study of Aripiprazole (Abilify) in Patients With Bipolar ManiaCompletedNCT00261443Phase 4Results posted
• Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical TrialsCompletedNCT00239356Phase 3Results posted
• A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)CompletedNCT00234104Phase 2Results posted
• Dose-response Study of OPC-12759 Ophthalmic SuspensionCompletedNCT00234078Phase 2Results posted
• Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)CompletedNCT00234065Phase 4Results posted
• Post-marketing Clinical Study of Rebamipide in Patients With Gastric UlcerCompletedNCT00233389Phase 4Results posted
• Exploratory Study for Dry Mouth in Patients With Sjögren's SyndromeCompletedNCT00233363Phase 2Results posted
• Study for the Treatment of Crohn's Disease With AdacolumnCompletedNCT00162942Phase 3Results posted
• Aripiprazole in Children and Adolescents With Bipolar I DisorderCompletedNCT00110461Phase 3Results posted
• A Study of Aripiprazole in Patients With Major Depressive DisorderCompletedNCT00105196Phase 3Results posted
• Aripiprazole Open-Label, Safety and Tolerability StudyCompletedNCT00102518Phase 3Results posted
• Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and AdolescentsCompletedNCT00102479Phase 1Results posted
• Aripiprazole in Adolescents With SchizophreniaCompletedNCT00102063Phase 3Results posted
• Evaluating the Efficacy of the Flush Advanced+ Dietary Supplement Drink Mix Compared to a Placebo in Women Ages 18-75 With a History of Recurrent, Bothersome Urinary Tract SymptomsActive, not recruitingNCT07856550Not applicable
• First-in-Human Safety and Tolerability Study of OPF-110 in Healthy AdultsActive, not recruitingNCT07848334Phase 1
• Bonafide Sleep Supplement for Menopausal Women With Sleep ComplaintsCompletedNCT07839312Not applicable
• Bonafide Sleep Supplement for Menopausal Women With Impaired SleepCompletedNCT07839299Not applicable
• The Effects of an Orally-Administered Probiotic on Vaginal SymptomsCompletedNCT07829861Not applicable
• How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male ParticipantsCompletedNCT07573449Phase 1
• A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive EpisodeCompletedNCT07549581Phase 1
• Trial to Demonstrate the Equivalence of Two Different Strengths of Oral Centanafadine Capsules in Healthy SubjectsCompletedNCT07486895Phase 1

← Otsuka Holdings Co., Ltd. overview and focus areas